FARXIGA for CKD | Heart Failure | Type 2 Diabetes
farxiga® (dapagliflozin), a medication for people with chronic kidney disease (ckd), heart failure with symptoms, and type 2 diabetes.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 224.204 |
| 2025-03 | 226.417 |
| 2025-04 | 271.856 |
| 2025-05 | 252.71 |
| Source | Traffic Share |
|---|---|
| search | 66.30% |
| direct | 23.32% |
| referrals | 5.13% |
| paid referrals | 3.70% |
| social | 1.50% |
| 0.04% |
| Region | Percentage |
|---|---|
| United States | 91.78% |
| PR | 2.17% |
| Canada | 1.89% |
| United Kingdom | 1.81% |
| India | 0.82% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| farxiga | 10,025 | 100,250 | $3.66 |
| farxiga coupon | 433 | 4,330 | $3.98 |
| kidney failure | 6,598 | 65,980 | $1.00 |
| farxiga patient assistance | 100 | 1,000 | $7.81 |
| egfr | 19,590 | 195,900 | $1.18 |